Build, discover and catalyse
BioTrinity, now in its 13th year, is Europe’s leading Biopartnering and Investment conference, and generates unrivalled opportunities for life science companies, academics, investors, and major pharmaceutical players to come together to do deals and establish collaborations. BioTrinity 2019 incorporates significant improvements. The focus of the 2019 conference is to look at 'What’s new' in the industry, including updates and insight on both technical and financial developments across a wide range of key therapeutics areas.
Both Nigel Davis and Sally Waterman will be attending the event.